Literature DB >> 10569410

Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear.

B J Conlon1, W P Gibson.   

Abstract

OBJECTIVE: This study analyzes the incidence of endolymphatic hydrops in the asymptomatic contralateral ear of patients with classic Meniere's disease. STUDY
DESIGN: A retrospective study of 3000 subjects who underwent electrocochleography (ECOG) from 1988 to 1998.
METHODS: The presence of endolymphatic hydrops was determined by use of ECOG recordings, which were made through a transtympanic recording needle situated in the round window niche. Analysis was made of the 1-kHz toneburst summation potential (SP), and comparison was made between asymptomatic contralateral "Meniere's ears" (n = 144) and asymptomatic normal "control ears" (n = 114).
RESULTS: Results demonstrated that more than 10% of the contralateral asymptomatic Meniere's ears have an ECOG recording that is highly suggestive of the presence of endolymphatic hydrops. In contrast, less than 2% of the control population demonstrate abnormal ECOG recordings. Furthermore, 15% of the population of contralateral Meniere's ears lie above the 95th percentile of the control population for 1-kHz tone-burst (100 dB) SP negativity.
CONCLUSIONS: This study suggests that a high percentage of patients who have what appears to be unilateral Meniere's disease have evidence of endolymphatic hydrops in the contralateral asymptomatic ear. This finding has important clinical relevance for the management of patients in whom destructive surgery is planned and further highlights the importance of electrocochleography in the diagnosis and management of this disease process.

Entities:  

Mesh:

Year:  1999        PMID: 10569410     DOI: 10.1097/00005537-199911000-00014

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  [Diagnosis of endolymphatic hydrops using low frequency modulated distortion product otoacoustic emissions].

Authors:  A Hirschfelder; E Gossow-Müller-Hohenstein; J Hensel; G Scholz; D Mrowinski
Journal:  HNO       Date:  2005-07       Impact factor: 1.284

2.  Intratympanic gentamicin in monolateral Meniere's disease: our experience.

Authors:  Giulia Bertino; Domenico Durso; Marco Manfrin; Luca Casati; Eugenio Mira
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-15       Impact factor: 2.503

3.  Clinical utility of electrocochleography in the diagnosis and management of Ménière's disease: AOS and ANS membership survey data.

Authors:  Linda T Nguyen; Jeffrey P Harris; Quyen T Nguyen
Journal:  Otol Neurotol       Date:  2010-04       Impact factor: 2.311

4.  Endolymphatic hydrops detected by 3-dimensional fluid-attenuated inversion recovery MRI following intratympanic injection of gadolinium in the asymptomatic contralateral ears of patients with unilateral Ménière's disease.

Authors:  Yupeng Liu; Huan Jia; Jun Shi; Hui Zheng; Yuhua Li; Jun Yang; Hao Wu
Journal:  Med Sci Monit       Date:  2015-03-06

5.  Anatomical Variations in Patients with Ménière Disease: A Tomography Study.

Authors:  Lucas Resende Lucinda; Daniela Dranka Cristoff; Luiz Otávio De Mattos Coelho; Otávio Pereira Lima Zanini; Rita De Cassia Cassou Guimarães
Journal:  Int Arch Otorhinolaryngol       Date:  2017-08-28

6.  Low-Dose Intratympanic Gentamicin for Unilateral Ménière's Disease: Accuracy of Early Vestibulo-Ocular Reflex Gain Reduction in Predicting Long-Term Clinical Outcome.

Authors:  Ricardo Wegmann-Vicuña; Raquel Manrique-Huarte; Diego Calavia-Gil; Eduardo Martín-Sanz; Pedro Marques; Nicolas Perez-Fernandez
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

Review 7.  Tone Burst Electrocochleography for the Diagnosis of Clinically Certain Meniere's Disease.

Authors:  Jeremy Hornibrook
Journal:  Front Neurosci       Date:  2017-06-16       Impact factor: 4.677

8.  Vestibular evoked myogenic potentials in affected and asymptomatic ears in unilateral Ménière's disease.

Authors:  Súnia Ribeiro; Roberta R de Almeida; Heloisa H Caovilla; Maurício M Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2006-01-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.